Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US 8,716,247 Lapsed on the fee recordLapsed May 6, 2026 on the fee record · From the USPTO record
20-year base term ends Feb 28, 2027
Third maintenance fee unpaid; grace period ended.
Feb 28, 2007
May 6, 2026
May 6, 2014
Apr 6, 2027
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 28, 2007, when the earliest non-provisional application in its chain was filed (this one was filed Nov 28, 2011) | Feb 28, 2027 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | +37 days, USPTO patent term adjustment record | Apr 6, 2027 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 2 of 3 maintenance fees paid | lapsed May 6, 2026 | USPTO record |
| Computed term end | The steps above, in order | May 6, 2026 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.